Company Filing History:
8 out of 1,504 
1 out of 11 
1 out of 12 Years Active: 2000-2023
Title: Qiang Yu: Innovator in Cancer Research
Introduction
Qiang Yu is a prominent inventor based in Singapore, known for his significant contributions to cancer research. With a total of 9 patents, he has developed innovative methods and compositions aimed at improving cancer diagnosis and treatment.
Latest Patents
One of his latest patents is a method of identifying the risk of cancer in human subjects. This method involves determining whether a copy number amplification of a specific genomic region on human chromosome 1q21 is present in a biological sample. The presence of this amplification indicates an elevated risk of cancer. Additionally, he has developed a method for treating cancer in subjects with this amplification by administering therapeutic agents that suppress IRAK1, IRAK4, or members of the S100 family, such as Pacritinib. Another notable patent focuses on a composition for modulating IRAK1, particularly in the treatment of triple-negative breast cancer (TNBC). This invention utilizes an inhibitor of IRAK1, such as ginsenosides, and includes methods for assessing prognosis and selecting therapeutic strategies based on IRAK1 activity levels.
Career Highlights
Qiang Yu has worked with esteemed organizations such as the Agency for Science, Technology and Research and Advanced Systems Automation Limited. His work in these institutions has allowed him to advance his research and contribute to the field of cancer treatment significantly.
Collaborations
He has collaborated with notable colleagues, including Jing Kai Tan and Xiao Jing Yang, to further enhance his research efforts and innovations in cancer therapies.
Conclusion
Qiang Yu's innovative work in cancer research exemplifies the impact of scientific advancements on healthcare. His patents and methods are paving the way for improved cancer diagnosis and treatment options.